AGXT2L2 Polyclonal Antibody

This is a nuclear gene PHYKPL encoding a mitochondrial enzyme that catalyzes the conversion of 5-phosphonooxy-L-lysine to ammonia, inorganic phosphate, and 2-aminoadipate semialdehyde. Mutations in PHYKPL (5-phosphohydroxy-L-lysine phospho-lyase) may cause phosphohydroxylysinuria. Alternative splicing results in multiple transcript variants.

The AGXT2L2 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of AGXT2L2 protein expression in various biological samples. This antibody has been rigorously validated and exhibits exceptional performance in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The AGXT2L2 Polyclonal Antibody is produced using state-of-the-art techniques, ensuring high purity and batch-to-batch consistency. It has been extensively characterized to ensure specificity, with minimal cross-reactivity to other related proteins. This antibody recognizes the AGXT2L2 protein with high affinity, enabling accurate and reliable quantification of its expression levels.

With its superior sensitivity, the AGXT2L2 Polyclonal Antibody allows for the detection of low-abundance AGXT2L2 protein in complex biological samples. Its robust performance ensures reproducible results, making it an ideal choice for both basic research and clinical applications.

The AGXT2L2 Polyclonal Antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size, allowing for multiple experiments without the need for frequent reordering. The antibody is stable and can be stored at recommended temperatures for an extended period without compromising its performance.

In summary, the AGXT2L2 Polyclonal Antibody is a reliable and versatile tool for the detection and analysis of AGXT2L2 protein expression. Its exceptional sensitivity, specificity, and stability make it an invaluable asset for researchers and clinicians alike.